2018
Tablet-based Hearing Screening in Children Aged 5 to 17 in Rural Dominican Republic
Levy DA, Hill DR, Bia FJ, Feinn RS. Tablet-based Hearing Screening in Children Aged 5 to 17 in Rural Dominican Republic. Otology & Neurotology 2018, 39: 823-828. PMID: 29995002, DOI: 10.1097/mao.0000000000001857.Peer-Reviewed Original ResearchConceptsTablet audiometerTablet audiometryAir conduction thresholdRural Dominican RepublicHearing screeningSchool-aged childrenChildren Aged 5Inclusion criteriaConduction thresholdLoss screeningAudiological servicesScreening protocolAged 5La RomanaAudiometryChildrenCohortScreeningAudiometerRemote communitiesDurationSubjectsDominican RepublicExpeditious meansYears
2008
Persistent and Relapsing Babesiosis in Immunocompromised Patients
Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR, Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D, Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Hartman B, Telford SR, Christianson D, Dardick K, Coleman M, Girotto JE, Spielman A. Persistent and Relapsing Babesiosis in Immunocompromised Patients. Clinical Infectious Diseases 2008, 46: 370-376. PMID: 18181735, DOI: 10.1086/525852.Peer-Reviewed Original ResearchConceptsCase patientsAntibabesial treatmentClinical courseControl subjectsBlood smearsRetrospective case-control studyOptimal treatment regimenStandard antimicrobial therapyMalaria-like illnessBabesia microti infectionMost cases patientsCase-control studyCourse of therapyB-cell lymphomaAdministration of atovaquoneImmunologic statusStandard therapyAntimicrobial regimenSuch patientsTreatment regimenMicroti infectionAntimicrobial therapyPersistent infectionCell lymphomaAcute babesiosis
2007
Fellows’ Forum in Dialysis :edited by Mark A. Perazella: Nontuberculous Mycobacterial Peritonitis in Peritoneal Dialysis Patients
Rho M, Bia F, Brewster UC. Fellows’ Forum in Dialysis :edited by Mark A. Perazella: Nontuberculous Mycobacterial Peritonitis in Peritoneal Dialysis Patients. Seminars In Dialysis 2007, 20: 271-276. PMID: 17555495, DOI: 10.1111/j.1525-139x.2007.00289.x.Peer-Reviewed Case Reports and Technical NotesConceptsPeritoneal dialysis patientsMycobacterial peritonitisDialysis patientsSerious intra-abdominal complicationsMark A. PerazellaPrompt catheter removalIntra-abdominal complicationsCases of peritonitisPatient risk factorsManagement of PDCatheter removalPrompt diagnosisTherapeutic challengeRisk factorsAntimicrobial therapyUnique presentationAppropriate diagnosisMycobacterial infectionTreatment strategiesPeritonitisMycobacterium chelonaeInfectionDiagnosisMycobacterium gordonaePatientsNecrotizing nocardial scleritis after combined penetrating keratoplasty and phacoemulsification with intraocular lens implantation: a case report and review of the literature
Ramos-Esteban JC, Servat JJ, da Silva R, Ambrósio R, Tauber S, Bia F. Necrotizing nocardial scleritis after combined penetrating keratoplasty and phacoemulsification with intraocular lens implantation: a case report and review of the literature. Arquivos Brasileiros De Oftalmologia 2007, 70: 355-359. PMID: 17589714, DOI: 10.1590/s0004-27492007000200031.Peer-Reviewed Case Reports and Technical NotesMeSH KeywordsAbscessAged, 80 and overAnterior ChamberAnti-Bacterial AgentsDrug Therapy, CombinationEye Infections, BacterialFemaleFuchs' Endothelial DystrophyHumansKeratoplasty, PenetratingLens Implantation, IntraocularNecrosisNocardia asteroidesNocardia InfectionsOphthalmic SolutionsPhacoemulsificationScleritisUveitis, AnteriorVisual AcuityConceptsCombined penetrating keratoplastyIntraocular lens implantationScleral perforationNecrotizing scleritisLens implantationPenetrating keratoplastySurgical specimensAnterior necrotizing scleritisInfectious necrotizing scleritisPrompt surgical interventionInfectious disease specialistsDonor corneal tissueTopical amikacinUveal prolapseVisual lossClinical presentationInfectious causesScleral reinforcementDisease specialistsFuchs' dystrophySurgical interventionCase reportMicrobiologic studiesPathological diagnosisSuccessful treatment
2002
Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis
Finkelstein ES, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. American Journal Of Kidney Diseases 2002, 39: 1278-1286. PMID: 12046042, DOI: 10.1053/ajkd.2002.33403.Peer-Reviewed Original ResearchConceptsLong-term peritoneal dialysisEpisodes of infectionPeritoneal dialysisCatheter changeRepeat infectionsLong-term peritoneal dialysis (PD) therapyMultiple episodesEnd-stage renal diseaseCause of peritonitisPeritoneal dialysis therapyAntibiotic sensitivity patternCulture-positive peritonitisPattern of infectionSpearman correlation testPeritonitis episodesSubsequent peritonitisPeritoneal catheterRenal diseaseDialysis therapyCausative organismPeritonitisPatientsSensitivity patternSame organismInfection
1998
Human Granulocytic Ehrlichiosis During Pregnancy Treated Successfully with Rifampin
Buitrago MI, IJdo JW, Rinaudo P, Simon H, Copel J, Gadbaw J, Heimer R, Fikrig E, Bia FJ. Human Granulocytic Ehrlichiosis During Pregnancy Treated Successfully with Rifampin. Clinical Infectious Diseases 1998, 27: 213-215. PMID: 9675481, DOI: 10.1086/517678.Peer-Reviewed Case Reports and Technical Notes
1992
MEDICAL CONSIDERATIONS FOR THE PREGNANT TRAVELER
Bia F. MEDICAL CONSIDERATIONS FOR THE PREGNANT TRAVELER. Infectious Disease Clinics Of North America 1992, 6: 371-388. PMID: 1624782, DOI: 10.1016/s0891-5520(20)30447-5.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPregnant travelersHigh-altitude trekkingRisk of diseaseVaccine complicationsMalaria prophylaxisVigorous exerciseClinical informationUnnecessary exposureMedical considerationsPlasmodium speciesAntiparasitic agentsCommercial air travelWidespread resistanceRiskProphylaxisComplicationsPregnancyImmunizationFetusesDiseaseCareComparison of enzyme-linked immunosorbent and indirect immunofluorescence assays for the detection of human T-cell lymphotropic virus type-I antibodies in sera from rural Haiti
Grant W, Bia F, Chacko T, Jean-Baptiste M, Griffith B. Comparison of enzyme-linked immunosorbent and indirect immunofluorescence assays for the detection of human T-cell lymphotropic virus type-I antibodies in sera from rural Haiti. Diagnostic Microbiology And Infectious Disease 1992, 15: 121-124. PMID: 1572136, DOI: 10.1016/0732-8893(92)90034-q.Peer-Reviewed Original ResearchConceptsWestern blotHuman T-cell lymphotropic virus type IHuman T-cell lymphotropic virusEnzyme immunoassayRural HaitiLymphotropic virus type IRural Haitian populationUninfected H9 cellsPrevalence of HTLVMT-2 cellsPositive samplesEnzyme-linked immunosorbentVirus type IAvailable enzyme immunoassayIndirect immunofluorescence assaysNeurologic diseaseLymphotropic virusH9 cellsHealthy individualsIndirect immunofluorescenceImmunofluorescence assaysSerum samplesHaitian populationSerumHTLVMalaria prophylaxis: taking aim at constantly moving targets.
Bia F. Malaria prophylaxis: taking aim at constantly moving targets. The Yale Journal Of Biology And Medicine 1992, 65: 329-36. PMID: 1290274, PMCID: PMC2589577.Peer-Reviewed Original ResearchConceptsMalaria infectionPlasmodium vivax resistanceChloroquine-resistant strainsVivax resistancePatient populationAdjunctive measuresCertain antimalarialsNumber of womenChemoprophylaxisPalatable formulationsMalaria riskPlasmodium falciparumInfectionPreventionContinued emergenceChildrenToxicityDifferent toxicitiesPotential implicationsGeographic regionsPregnancyRepellent formulationsCliniciansAntimalarialsFalciparum
1991
Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice.
Colson ER, Horwitz RI, Bia FJ, Viscoli CM. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice. JAMA Internal Medicine 1991, 151: 709-13. PMID: 2012453, DOI: 10.1001/archinte.151.4.709.Peer-Reviewed Original ResearchConceptsZidovudine therapyDosage reductionAdverse outcomesHuman immunodeficiency virus type 1 (HIV-1) infectionClinical practiceHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Observational cohort studyHuman immunodeficiency virusTreatment of patientsType 1 infectionVirus type 1Zidovudine dosageCohort studyMost patientsImmunodeficiency virusBaseline cytopeniasTreatment outcomesPatterns of usePatientsTherapyType 1Dosage changesMonths
1990
Recurrent aseptic meningitis for 24 years: diagnosis and treatment of an associated lesion.
Frieden T, Piepmeier J, Murdoch G, Bia F. Recurrent aseptic meningitis for 24 years: diagnosis and treatment of an associated lesion. The Yale Journal Of Biology And Medicine 1990, 63: 593-9. PMID: 2092416, PMCID: PMC2589416.Peer-Reviewed Original ResearchConceptsRecurrent aseptic meningitisAseptic meningitisCausative organismEpisodes of meningitisRecurrent lymphocytic meningitisInfectious disease consultationLeft lateral ventricleComputerized tomographic head scanningRecurrent meningitisCavernous hemangiomaLymphocytic meningitisDiagnostic challengeMagnetic resonance imaging techniquesLateral ventricleMeningitisAnatomical sourceHead scansDisease processLesionsPatientsImaging techniquesYearsHemangiomaVentriclePhysical agents
1987
Effects of Cyclosporine on Chronic Cytomegalovirus Infection in the Guinea Pig
Markham D, Griffith B, Lerner E, Lucia H, Bia F. Effects of Cyclosporine on Chronic Cytomegalovirus Infection in the Guinea Pig. Intervirology 1987, 28: 171-180. PMID: 2836336, DOI: 10.1159/000150013.Peer-Reviewed Original ResearchConceptsCytomegalovirus infectionLymphoid tissueGuinea pig cytomegalovirus infectionDetectable systemic diseaseGPCMV-infected animalsChronic cytomegalovirus infectionEffect of cyclosporineCMV isolationImmunosuppressed groupSystemic diseaseGuinea pigsExperimental animalsCs immunosuppressionCyclosporineIsolation rateDrug vehicleInfectionTissueAnimalsImmunosuppressionGavageDisease
1985
Effects of Cyclosporine on the Pathogenesis of Primary Cytomegalovirus Infection in the Guinea Pig
Bia F, Lucia H, Bia M, Vine W, Tuttle A. Effects of Cyclosporine on the Pathogenesis of Primary Cytomegalovirus Infection in the Guinea Pig. Intervirology 1985, 24: 154-165. PMID: 2999030, DOI: 10.1159/000149635.Peer-Reviewed Original ResearchConceptsPrimary cytomegalovirus infectionGuinea pigsCytomegalovirus infectionPrimary CMV infectionEffect of cyclosporinePresence of CMVGuinea pig CMVGuinea pig modelInternal organsHartley guinea pigsTotal body weightUntreated controlsCMV isolationOral CsACMV infectionCsA administrationLymphocyte valuesLymphocytes/Inflammatory responseMean changeViral inclusionsBody weightPig modelDay 0CMV
1984
Vaccination Against Transplacental Cytomegalovirus Transmission: Vaccine Reactivation and Efficacy in Guinea Pigs
Bia F, Miller S, Lucia H, Griffith B, Tarsio M, Hsiung G. Vaccination Against Transplacental Cytomegalovirus Transmission: Vaccine Reactivation and Efficacy in Guinea Pigs. The Journal Of Infectious Diseases 1984, 149: 355-362. PMID: 6325549, DOI: 10.1093/infdis/149.3.355.Peer-Reviewed Original ResearchConceptsCMV infectionSubsequent pregnancyThroat swabsCMV transmissionGuinea pigsNonpregnant control animalsCongenital CMV infectionTissue culture infective dosesHartley strain guinea pigsGuinea pig modelCMV vaccineCytomegalovirus transmissionCytomegalovirus infectionFetal infectionPregnant controlsAcute viremiaGeneralized infectionCytomegalovirus vaccineControl animalsInfective dosesPregnancyPregnant animalsVaccineInfectionSwabs
1983
Histopathologic and ultrastructural studies of disseminated cytomegalovirus infection in strain 2 guinea pigs.
Fong C, Lucia H, Bia F, Hsiung G. Histopathologic and ultrastructural studies of disseminated cytomegalovirus infection in strain 2 guinea pigs. Laboratory Investigation 1983, 49: 183-94. PMID: 6308346.Peer-Reviewed Original ResearchConceptsStrain 2 guinea pigsGuinea pigsCytomegalovirus infectionSalivary glandsViral inclusionsCultured guinea pig cellsGuinea pig cytomegalovirus infectionDisseminated cytomegalovirus infectionSevere disseminated diseaseHigh mortality rateUseful animal modelGland duct cellsSalivary gland duct cellsDisseminated diseaseGuinea pig cellsHistologic examinationElectron microscopic examinationAnimal modelsMortality rateVirus inoculationGross lesionsInfectious virusVisceral tissuesPig cellsIntranuclear inclusionsCytomegaloviral Infections in the Guinea Pig: Experimental Models for Human Disease
Bia F, Griffith B, Fong C, Hsiung G. Cytomegaloviral Infections in the Guinea Pig: Experimental Models for Human Disease. Clinical Infectious Diseases 1983, 5: 177-195. PMID: 6302812, DOI: 10.1093/clinids/5.2.177.Peer-Reviewed Original ResearchConceptsGuinea pig cytomegalovirusInterstitial pneumoniaTransplacental transmissionGuinea pigsPrimary CMV infectionPolymorphonuclear leukocyte functionGuinea pig modelSalivary gland virusHuman viral infectionsCongenital infectionCytomegaloviral infectionCMV infectionBlood transfusionFungal superinfectionsViremic infectionAntigen vaccineTransmission of virusesSuch vaccinesLeukocyte functionHuman diseasesCocultivation techniquesViral infectionPig modelCytomegalovirusInfectious diseases
1982
Effects of Vaccination on Cytomegalovirus-Associated Interstitial Pneumonia in Strain 2 Guinea Pigs
Bia F, Lucia H, Fong C, Tarsio M, Hsiung G. Effects of Vaccination on Cytomegalovirus-Associated Interstitial Pneumonia in Strain 2 Guinea Pigs. The Journal Of Infectious Diseases 1982, 145: 742-747. PMID: 6281341, DOI: 10.1093/infdis/145.2.742.Peer-Reviewed Original ResearchConceptsStrain 2 guinea pigsInterstitial pneumoniaCMV infectionGuinea pigsMinimal histopathologic changesTissue culture infective dosesBilateral interstitial pneumoniaEffect of vaccinationStudy of pathogenesisGuinea pig cytomegalovirusHistologic evidenceHistopathologic changesPneumoniaVaccinated animalsInfective dosesCytomegalovirusInfectionLungInfected tissuesPathogenesisPigsTissuePreventionAnimalsViremiaNeutrophil response and function during acute cytomegalovirus infection in guinea pigs
Yourtee E, Bia F, Griffith B, Root R. Neutrophil response and function during acute cytomegalovirus infection in guinea pigs. Infection And Immunity 1982, 36: 11-16. PMID: 6281184, PMCID: PMC351177, DOI: 10.1128/iai.36.1.11-16.1982.Peer-Reviewed Original ResearchConceptsAcute cytomegalovirus infectionTissue culture infective dosesCytomegalovirus infectionPolymorphonuclear leukocytesGuinea pig cytomegalovirusPeritoneal polymorphonuclear leukocytesGuinea pigsInfected animalsInflammatory stimuliUninfected controlsInfective dosesHartley strain guinea pigsType of infectionPhorbol myristate acetateAcute infectionGranulocyte numbersNeutrophil responseCasein injectionNeutrophil activatorInflammatory sitesBacterial stimuliControl animalsBone marrowDecreased mobilizationBacterial killing
1981
Cytomegalovirus-induced mononucleosis in guinea pigs
Griffith B, Lucia H, Bia F, Hsiung G. Cytomegalovirus-induced mononucleosis in guinea pigs. Infection And Immunity 1981, 32: 857-863. PMID: 6265366, PMCID: PMC351522, DOI: 10.1128/iai.32.2.857-863.1981.Peer-Reviewed Original ResearchConceptsGuinea pigsAcute infectionLymphoid tissueBone marrowB-lymphocyte-enriched populationsTransient hematological changesB-cell areasCMV mononucleosisAtypical lymphocytesCMV infectionCytomegalovirus infectionLymph nodesBlood countMononuclear cellsChronic infectionSpleen sizeHematological changesSplenic macrophagesVirus persistenceVirus inoculationInfectionBlood parametersVirus distributionMononucleosisSpleen
1980
Vaccination for the Prevention of Maternal and Fetal Infection with Guinea Pig Cytomegalovirus
Bia F, Griffith B, Tarsio M, Hsiung G. Vaccination for the Prevention of Maternal and Fetal Infection with Guinea Pig Cytomegalovirus. The Journal Of Infectious Diseases 1980, 142: 732-738. PMID: 6257798, DOI: 10.1093/infdis/142.5.732.Peer-Reviewed Original ResearchConceptsFetal infectionAcute viremiaPregnant animalsGuinea pigsGuinea pig cytomegalovirusCMV vaccineAntigen vaccineNonimmune controlsCytomegalovirus vaccineLower incidenceControl animalsImmunized animalsVaccinated animalsCMVViremiaVaccineVirulent virusInfectionSerial passageAnimalsPigsDense bodiesTissue cultureVaccinationCytomegalovirus